The U.S. is currently facing 323 ongoing drug shortages, the highest number since tracking began in 2001. These shortages are concerning due to the potential harm to patients. Basic and life-saving medicines like oxytocin, Rho(D) immune globulin, chemotherapy, pain/sedation medications, and ADHD pills are in short supply. The reasons for these shortages are varied and often unclear, with 60% of cases lacking explanations from drug manufacturers. The University of Utah Drug Information Service tracks shortages, providing data published by the American Society of Health-System Pharmacists. This ongoing issue highlights the need for addressing drug shortages in the U.S. Healthcare system.
Source link
Drug shortages reached a record high as 2023 drew to a close
